Gokul Vallimuthu
Gokul Vallimuthu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Chandana Maji
Department of Pharmaceutical Chemistry, Noida Institute of Engineering and Technology (Pharmacy Institute), Knowledge Park-II, Greater Noida
1 shared publication - D. Akiladevi
Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, Pallavaram, Chennai, Tamilnadu, India
1 shared publication - Divya Raj Singh
Department of Pharmacy Practice , Teerthanker Mahaveer College of Pharmacy, Teerthanker, Mahaveer University, Moradabad UP,India
1 shared publication Gayatri R. Katole
Nagpur College of pharmacy, wanadongri, Hingna road, Nagpur, Maharashtra, India
1 shared publicationRajadevi Ravi
School of Pharmacy, SBV Chennai, Sri Balaji Vidyapeeth (Deemed to be University), Puducherry, India
1 shared publication- Ramish Maqsood
Department of Biotechnology, Noida Institute of Engineering and Technology, Knowledge Park-II, Greater Noida
1 shared publication
Latest Publications
- Open Access
- 30 October 2026
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 5 (42) , 2202
Synthesis and Biological Evaluation of Coumarin Derivatives Targeting Oxidative Stress in Neurodegenerative Diseases
Neurodegenerative disorders, particularly Alzheimer’s disease, are closely associated with oxidative stress, cholinergic dysfunction, and progressive neuronal damage. In the present study, a series of coumarin derivatives (C1–C6) was designed, synthesized, and evaluated for their antioxidant and acetylcholinesterase inhibitory potential with the aim of identifying multifunctional lead compounds for neurodegenerative disorders. The coumarin scaffold was selected because of its well-established pharmacological versatility and its ability to accommodate structural modifications that may enhance biological activity. The synthesized derivatives were characterized by physicochemical analysis and Fourier-transform infrared spectroscopy, which confirmed the presence of characteristic functional groups such as hydroxyl, lactone carbonyl, aromatic C=C, and C–O moieties. Antioxidant activity was assessed using DPPH, ABTS, and ferric-reducing antioxidant power assays, while acetylcholinesterase inhibition was evaluated as a neurodegeneration-relevant target-based parameter. The results demonstrated that all compounds exhibited varying degrees of antioxidant and enzyme inhibitory activity depending on the nature of the substituents present on the coumarin nucleus. Among the tested derivatives, compound C4 showed the most promising overall biological profile, with comparatively lower IC₅₀ values in the DPPH and ABTS assays, higher ferric-reducing potential, and the strongest acetylcholinesterase inhibitory activity among the synthesized compounds. Structure–activity relationship analysis suggested that hydroxyl substitution significantly enhanced antioxidant activity, while appropriate electronic and steric features also contributed to enzyme inhibition. Overall, the findings indicate that rational modification of the coumarin scaffold can generate multifunctional derivatives with potential relevance in the management of oxidative stress-mediated neurodegenerative disorders. These results support further studies involving molecular docking, ADMET profiling, cellular models, and in vivo neuroprotective evaluation of the lead compound.
- 30 October 2026
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 5 (42) , 2202
Open AccessSynthesis and Biological Evaluation of Coumarin Derivatives Targeting Oxidative Stress in Neurodegenerative Diseases
Neurodegenerative disorders, particularly Alzheimer’s disease, are closely associated with oxidative stress, cholinergic dysfunction, and progressive neuronal damage. In the present study, a series of coumarin derivatives (C1–C6) was designed, synthesized, and evaluated for their antioxidant and acetylcholinesterase inhibitory potential with the aim of identifying multifunctional lead compounds for neurodegenerative disorders. The coumarin scaffold was selected because of its well-established pharmacological versatility and its ability to accommodate structural modifications that may enhance biological activity. The synthesized derivatives were characterized by physicochemical analysis and Fourier-transform infrared spectroscopy, which confirmed the presence of characteristic functional groups such as hydroxyl, lactone carbonyl, aromatic C=C, and C–O moieties. Antioxidant activity was assessed using DPPH, ABTS, and ferric-reducing antioxidant power assays, while acetylcholinesterase inhibition was evaluated as a neurodegeneration-relevant target-based parameter. The results demonstrated that all compounds exhibited varying degrees of antioxidant and enzyme inhibitory activity depending on the nature of the substituents present on the coumarin nucleus. Among the tested derivatives, compound C4 showed the most promising overall biological profile, with comparatively lower IC₅₀ values in the DPPH and ABTS assays, higher ferric-reducing potential, and the strongest acetylcholinesterase inhibitory activity among the synthesized compounds. Structure–activity relationship analysis suggested that hydroxyl substitution significantly enhanced antioxidant activity, while appropriate electronic and steric features also contributed to enzyme inhibition. Overall, the findings indicate that rational modification of the coumarin scaffold can generate multifunctional derivatives with potential relevance in the management of oxidative stress-mediated neurodegenerative disorders. These results support further studies involving molecular docking, ADMET profiling, cellular models, and in vivo neuroprotective evaluation of the lead compound.